Moody Lynn & Lieberson LLC Purchases 10,426 Shares of iShares Biotechnology ETF $IBB

Moody Lynn & Lieberson LLC grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 192.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 15,831 shares of the financial services provider’s stock after purchasing an additional 10,426 shares during the quarter. Moody Lynn & Lieberson LLC’s holdings in iShares Biotechnology ETF were worth $2,672,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently made changes to their positions in the company. Aster Capital Management DIFC Ltd bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter valued at $1,907,000. Central Pacific Bank Trust Division increased its stake in shares of iShares Biotechnology ETF by 296,500.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock worth $2,503,000 after purchasing an additional 14,825 shares in the last quarter. SG Americas Securities LLC raised its holdings in iShares Biotechnology ETF by 96.3% in the 3rd quarter. SG Americas Securities LLC now owns 28,569 shares of the financial services provider’s stock worth $4,125,000 after purchasing an additional 14,016 shares during the period. Florin Court Capital LLP purchased a new position in iShares Biotechnology ETF during the third quarter valued at $11,116,000. Finally, Viewpoint Capital Management LLC lifted its position in iShares Biotechnology ETF by 1,532.1% during the third quarter. Viewpoint Capital Management LLC now owns 12,730 shares of the financial services provider’s stock valued at $1,838,000 after purchasing an additional 11,950 shares in the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB opened at $168.85 on Wednesday. The stock has a 50-day simple moving average of $170.97 and a two-hundred day simple moving average of $164.70. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.